IPXL Financial Facts

Research and development: 18.98M
Cost of revenues: 73.56M
See Full Income Statement

Accounts payable: 33.46M
Deferred income taxes: 51.84M
See Full Balance Sheet

Impax Laboratories Inc. (IPXL) Earnings

  |   Expand Research on IPXL
Next EPS Date 2/20/15 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate -98.4% Revenue Growth Rate +19.2% *Last Qtr.
Average % Move 1-Wk after EPS +1.6% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/4/14 Q314 $0.33$0.31 +$0.02$158M$148.36M N/A Details
8/6/14 Q214 $0.60$0.36 +$0.24$188.1M$155.97M N/A Details
5/1/14 Q114 $0.24N/A N/A $106M$97.8M N/A Details
2/20/14 Q413 -$0.14$0.03 -$0.17$100.74M$119.01M N/A Details
11/4/13 Q313 $0.00-$0.07 +$0.07$132.6M$111.83M N/A Details
8/8/13 Q213 $0.08$0.04 +$0.04$129.63M$120.75M N/A Details
5/1/13 Q113 $0.37$0.21 +$0.16$148.5M$128.85M N/A Details
2/25/13 Q412 $0.23$0.19 +$0.04$141.1M$127.03M N/A Details